You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 廣生堂漲停 新冠口服藥進入II/III期臨牀
格隆匯 12-16 09:56
格隆匯12月16日丨廣生堂(300436.SZ)快速拉昇封漲停板,現報48.6元,成交額放大至6.3億元,總市值77.4億元。公司昨日宣佈,抗新冠口服藥GST-HG171於近日獲得組長單位廣州醫科大學附屬第一醫院和深圳市第三人民醫院關於啟動II/III期臨牀試驗的倫理委員會審查批件,標誌着GST-HG171項目的II/III期無縫設計的關鍵性註冊臨牀研究已全面實質啟動。同時由研究者發起的在輕型/普通型新冠患者中評價初步藥效和安全性的臨牀研究(IIT研究)已順利完成全部患者入組和給藥,尚待總結報吿。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account